BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230510T093000
DTEND;TZID=Europe/London:20230510T133000
DTSTAMP:20260412T073149
CREATED:20230209T135310Z
LAST-MODIFIED:20230502T134952Z
UID:22185-1683711000-1683725400@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: The Fight Against Antibiotic Resistance: From Bench to Bedside
DESCRIPTION:The first Infectious Diseases Special Interest Group of 2023 brings together academic\, clinician and industry experts to explore the latest developments in the field of antibiotic resistance. We’re pleased to be able to hold this event in person at MeetPoint Midlands\, allowing ample opportunity for networking and discussion beyond our exciting panel of formal presentations. \nOur Chair\, Professor Katie Laird\, Professor of Microbiology at De Montfort University (DMU)\, will be joined on the day by: \n\nDr Rahmi Yusuf\, Lecturer in Pharmaceutical Microbiology\, DMU\nDr Grace Edmund\, Senior Computational Chemist\, Oxford Drug Design\nStephanie Lesage\, Co-Founder and CEO\, Oxford Silk Phage Technologies Ltd\n\nMoreover\, delegates are invited to deliver a 5-minute pitch relating to the broader SIG area. Use this time as you wish – to invite knowledge exchange on a particular area of the subject\, showcase a new development that you’re currently working on\, and to highlight collaborative opportunities to other innovators and facilitators in attendance. \nInterested in delivering a 5-minute pitch? Please email info@medilinkmidlands.com with your name\, company\, and an overview of what you wish to share within your timeslot. \nThis free-to-attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. \nPlease note: whilst this event is held as part of the SoLSTICE programme\, attendance is not restricted to companies in the Leicester/Leicestershire area and is open to all. \nCLICK HERE TO BOOK YOUR PLACE\nSpeaker Profiles \n \nDr Rahmi Yusuf\, Lecturer in Pharmaceutical Microbiology\, DMU \nPresentation topic: Designing a Biological Platform for High-Throughput Screening of Novel Antibacterial Compounds \nRahmi’s journey as a microbiologist began in her home country\, Indonesia\, after completing a Bachelor in Microbiology in 2008\, specialising in Industrial Microbiology. Following a number of short industry internships back home\, she enrolled in a graduate programme in Biomedical Engineering at Hochschule Furtwangen University\, Germany\, which she completed in 2012. Supported by a full government scholarship\, Rahmi then completed her doctoral studies at the University of Portsmouth in 2019\, researching the fundamental study of bacterial two-component systems and harnessing their potential as synthetic biosensors. Rahmi carried on this research for a further 2.5 years as a Senior Research Associate\, before joining the School of Pharmacy at DMU as Lecturer in Pharmaceutical Microbiology. \n \nDr Grace Edmund\, Senior Computational Chemist\, Oxford Drug Design \nPresentation title: Targeting Antibiotic Resistance through a Novel Class of Gram-Negative Antibacterial Agents \nDr Grace Edmund is a Senior Computational Chemist at Oxford Drug Design where she leads the computational chemistry effort for their tRNA synthetase antibacterial drug discovery project. Prior to joining Oxford Drug Design in 2015\, she completed post-doctoral research at the University of Surrey in collaboration with DSTL. She received her MChem in Chemistry from Durham University and PhD in Computational Chemistry from the University of Surrey. \n \nDr Stephanie Lesage\, Co-Founder & CEO\, Oxford Silk Phage Technologies Ltd \nPresentation title: Deploying Bacteriophages to Preserve Antibiotics \nStephanie Lesage has a multidisciplinary background in biological sciences (BSc)\, technical textile engineering (MEng) and medical devices (MSc)\, with 19 years of start-up leadership experience. She is CEO of Oxford Silk Phage Technologies Ltd\, a company she co-founded in 2020\, developing a novel antibacterial material integrating bacteriophages to produce medical implants which will reduce surgical site infections and antibiotic use. Stephanie is also a founding member of Phage-UK (2021)\, aiming to make phage therapy more widely available to UK patients and she was recently invited to the House of Commons to provide oral evidence on the potential for bacteriophage therapy in the UK.
URL:https://staging.medilinkmidlands.com/event/antibiotic-resistance/
LOCATION:MeetPoint Midlands\, Conference Centre\, 28 High Street\, Kegworth\, Derbyshire\, DE74 2DA
CATEGORIES:Medilink Midlands Event,Project Event
ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230517T093000
DTEND;TZID=Europe/London:20230517T133000
DTSTAMP:20260412T073149
CREATED:20230309T135351Z
LAST-MODIFIED:20230630T075331Z
UID:22595-1684315800-1684330200@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: NBIC Showcase: Supporting Collaboration for Impact in Biofilm Research
DESCRIPTION:  \n  \nDelegates at this event will hear about the extensive opportunities offered by the National Biofilm Innovation Centre (NBIC) and Medilink Midlands to support collaboration between academia and industry in the area of biofilm research and innovation. Presentations and tours will provide an opportunity to see the state-of-the-art facilities available to characterize biofilms at the University of Nottingham or through NBIC partners. \nA selection of projects that exemplify successful collaborations between academia and industry will be presented by experts in the field\, and there will be the opportunity for delegates to pitch ideas for new collaborations. Networking will be facilitated over coffee and lunch breaks\, during the tours and by interacting with allied support organisations who will be present. \nInnovation vouchers are available\, please click here to access the guidance: Innovation voucher guidance\nAgenda\n09.30 Arrival/registration/coffee \n10.00 Welcome and introductions: Kim Hardie (Biodiscovery Institute\, School of Life Sciences\, University of Nottingham & NBIC) and Caroline Sykes (Medilink Midlands) \n10.05 Miguel Cámara (Biodiscovery Institute\, School of Life Sciences\, University of Nottingham & NBIC): ‘Introduction to NBIC: Nottingham research and infrastructure‘ \n10.25 Platform facilities at the University of Nottingham \n\nTim Self/Robert Markus: ‘School of Life Sciences Imaging (SLIM): a world class facility’\nDr Matthew Piggott: ‘Nanoscale & Microscale Research Centre (nmRC): Correlative Imaging and Compositional Analysis’\n\n10.40 Pitch 1: Paul S Browning\, Freedom Hygiene Ltd \n10.45 Pitch 2: Jinju Chen (Vicky)\, Newcastle University \n10.50 Paul Williams (Biodiscovery Institute\, School of Life Sciences\, University of Nottingham): ‘Anti biofilm coatings on catheters’ TBC \n11.10 Coffee Break \n11.40 Alvaro Mata (School of Engineering\, University of Nottingham): ‘Biocooperative approaches to engineer biofilm models’ \n12.00 Sarah Kuehne (School of Dentistry\, University of Birmingham): ‘Oral biofilm models’ TBC \n12.20 Pitch 3: Jeni Luckett\, University of Nottingham \n12.25 Pitch 4: TBC \n12.30 Caroline Sykes (Medilink Midlands): ‘Nottingham City Shared Prosperity Fund opportunities.’ \n12.45 Summary and presentations conclude: Kim Hardie and Miguel Cámara \n13.00 Networking lunch \n13.30 Tours: \n\nBDI pathogen imaging/robots/compound library (Robert Markus)\nnmRC (Matt Piggott)\n\n15.30 Depart \nIn addition to the formal presentations\, we are also offering an optional tour\, which is anticipated to finish at 3pm. \nDirections and Arrival Information: For directions to the University Park campus as well as a detailed campus map\, please click here. The event is taking place in at the Boots Science Building\, which is building number 44 on the campus map. \nOn arrival to the Boots Science Building\, you will find the Medilink Midlands registration desk in the main foyer\, where you will need to sign and collect your name badge. \nArriving by Car: We have a limited number of event parking spaces available to our attendees (not applicable to University of Nottingham attendees). If you require a car parking space\, please let me know as soon as possible as these will be offered on a first-come\, first-served basis\, for which you will require a parking voucher. Alternatively\, delegates can park in the main Visitors Car Park which is located at the bottom of E2 on the campus map. Please note that there is a short walk from the main car park to the venue and that parking is pay and display. The parking fee can be paid either at the machine or via the RingGo app at a cost of £7 for 4 hours or £10 for the full day. \nArrival by Tram: We recommend the tram as a convenient mode of transport for this event. The University of Nottingham stop on the Toton Lane line arrives directly opposite the Boots Science Building (you just need to exit the bridge via the stairs). Further information is available via the NetGo app\, where you can also buy e-tickets for your journey. \nTour of the NBIC facilities:In addition to the formal presentations\, we are also offering an optional tour\, which is anticipated to finish at 3pm. \nThis free-to-attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  \nPlease note: whilst this event is held as part of the INSTILS programme\, attendance is not restricted to companies in the D2N2/NG area and is open to all.
URL:https://staging.medilinkmidlands.com/event/nbic-showcase/
LOCATION:University of Nottingham School of Pharmacy
CATEGORIES:Medilink Midlands Event,Project Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20230517T093000
DTEND;TZID=Europe/London:20230517T133000
DTSTAMP:20260412T073149
CREATED:20230330T121650Z
LAST-MODIFIED:20230515T142141Z
UID:22979-1684315800-1684330200@staging.medilinkmidlands.com
SUMMARY:IN-PERSON EVENT: 3D Technologies and Augmented Reality: Improving Surgical Planning and Intervention
DESCRIPTION:The next MedTech & Systems Special Interest Group event will be held in person\, with a focus on the latest developments in 3D technologies and augmented reality. The presentations will consider how these fields are creating significant improvements in surgical planning and intervention. \nToday\, the use of Augmented Reality (AR) and Virtual Reality (VR) in healthcare is expanding. Augmented Reality\, Virtual Reality and Extended Reality (XR) are now much more common terms linked to the delivery of realistic interactive experiences through real-life simulation and user immersion. Technologies including the Microsoft HoloLens and the Vuzix AR platforms have provided additional and exciting possibilities linked to healthcare and surgery. Surgeons rely on information from CT scans\, MRI’s\, X-rays and other patient data sources to determine surgical requirements and to preoperatively plan prior to a surgical procedure. If using wearable technologies\, this data could be represented in a surgeon’s line of sight\, utilising AR tools to potentially provide significant surgical procedural advantages during an operation and ultimately improve patient outcomes. \nChaired by Professor Phil Breedon\, Professor of Smart Technologies at Nottingham Trent University\, this session brings together a panel of leading experts\, including: \n\nJason Watson\, Consultant Maxillofacial Prosthetist\, Nottingham University Hospital\nRory O’Connor\, Consultant in Oral and Maxillofacial Surgery and Major Trauma\, Nottingham University Hospital\nDr Arsham Khayatpoor\, Medical Account Manager\, Materialise UK\n\nThis in-person event will also allow ample time for Q&A and networking. \nCLICK HERE TO SECURE YOUR PLACE TODAY\nThis free-to-attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  \nPlease note: whilst this event is held as part of the INSTILS programme\, attendance is not restricted to companies in the D2N2/NG area and is open to all. \nSpeaker Profiles \n \nJason Watson\, Consultant Clinical Scientist in Reconstructive Science\, Nottingham University Hospitals Trust \nJason completed his post graduate training at the Northern General Hospital\, Sheffield\, in the 1990s. Jason started his my own unit in Nottingham at the QMC in 2002\, where the laboratory has become one of the most innovative centres in the field of Maxillofacial Prosthetics and Reconstructive Science. \nJason has published over 30 papers and book chapters. He has also received national awards including the Chief Scientific Officers Award for Leadership and Innovation 2010 in recognition for establishing the first in-house 3D print service in the NHS. Jason has collaborated on numerous i4i and EPSRC grants (Loughborough University/Kings College & Leeds University) in the field of 3D acquisition\, printing and manufacture. \nJason co-wrote the Scientist Trailing Programme (STP) in Reconstructive Science (level 7) and was lead writer on the Higher Specialist Scientist (HSST) Consultant training (level 8) with the National School Healthcare Science and Royal College Surgeons (England). He established NUH as the field’s regional training centre in 2006 and has had the highest number of successful trainees through the national programme (STP) since its inception in 2013. Jason was invited by the British Association Oral Maxillofacial Surgeons (BAOMS) to deliver the Presidents Lecture in 2020\, becoming only the second scientist to do so in their history. Jason has been an active professional body council member throughout his career\, serving in numerous roles culminating in 3 years as the Chair of our association (IMPT) \nCurrently I enjoy exploring emerging technologies for clinical and technical use in real life situations\, sharing ideas and collaborating with new colleges\, cars\, motorbikes\, travel and food. \n \nRory O’Connor\, NHS Consultant in Oral and Maxillofacial Surgency and Major Trauma\, Queen’s Medical Centre\, Nottingham \nRory is an expert in facial trauma and post traumatic facial deformity with a particular focus on how technology can improve patient outcomes and make treatments more efficient. He has worked as a doctor all over the East Midlands\, in London\, Cambridge and Switzerland and is keen to collaborate with anyone who would like to improve how we look after the patients of the future. \n \nDr Arsham Khayatpoor\, Medical Account Manager\, Materialise
URL:https://staging.medilinkmidlands.com/event/in-person-event-3d-technologies-and-augmented-reality-improving-surgical-planning-and-intervention/
LOCATION:Dryden Enterprise Centre\, Nottingham
CATEGORIES:Medilink Midlands Event,Project Event
ORGANIZER;CN="Teresa O'Rourke":MAILTO:info@medilinkmidlands.com
END:VEVENT
END:VCALENDAR